YU3700A - Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba - Google Patents

Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba

Info

Publication number
YU3700A
YU3700A YU3700A YU3700A YU3700A YU 3700 A YU3700 A YU 3700A YU 3700 A YU3700 A YU 3700A YU 3700 A YU3700 A YU 3700A YU 3700 A YU3700 A YU 3700A
Authority
YU
Yugoslavia
Prior art keywords
calcium
preparations
containing vitamin
pharmaceutical compositions
compositions containing
Prior art date
Application number
YU3700A
Other languages
English (en)
Inventor
Maurizio Valleri
Alessandro Tosetti
Original Assignee
Menarini International Operations Luxembourg S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini International Operations Luxembourg S.A. filed Critical Menarini International Operations Luxembourg S.A.
Publication of YU3700A publication Critical patent/YU3700A/sh
Publication of RS49703B publication Critical patent/RS49703B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Ovde je opisana farmaceutska kompozicija koja se sastoji od vitamina D i kalcijuma, a sadrži sredstvo za vezivanje iz grupe koja se sastoji od: propilen glikola, polietilen glikola prikazane molarne težine izmedju 300 i 1500, tečnog parafina ili silikonskog ulja, a upotrebljava se za lečenje nutricionističkog nedostatka kalcijuma i vitamina D u starosti.[Described herein is a pharmaceutical composition containing vitamin D and calcium, comprising a binding agent chosen from among the group consisting of: propylene glycol, a polyethylene glycol presenting a molecular weight comprised between 300 and 1500, liquid paraffin or silicone oil, useful for the treatment of nutritional deficiency of calcium and vitamin D in the elderly.
YUP-37/00A 1997-07-30 1998-07-21 Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba RS49703B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97FI000184A ITFI970184A1 (it) 1997-07-30 1997-07-30 Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico

Publications (2)

Publication Number Publication Date
YU3700A true YU3700A (sh) 2002-11-15
RS49703B RS49703B (sr) 2007-12-31

Family

ID=11352223

Country Status (29)

Country Link
US (1) US7067154B1 (sh)
EP (1) EP0999843B1 (sh)
JP (1) JP4497496B2 (sh)
KR (1) KR100573421B1 (sh)
AT (1) ATE271387T1 (sh)
AU (1) AU8978198A (sh)
BG (1) BG65044B1 (sh)
BR (1) BR9810832B1 (sh)
CA (1) CA2299420C (sh)
CZ (1) CZ297670B6 (sh)
DE (1) DE69825164D1 (sh)
EA (1) EA002492B1 (sh)
EE (1) EE04046B1 (sh)
ES (1) ES2223135T3 (sh)
HK (1) HK1027751A1 (sh)
HU (1) HU226112B1 (sh)
ID (1) ID23504A (sh)
IL (1) IL134268A0 (sh)
IS (1) IS5359A (sh)
IT (1) ITFI970184A1 (sh)
NO (1) NO20000310L (sh)
PL (1) PL189295B1 (sh)
PT (1) PT999843E (sh)
RS (1) RS49703B (sh)
SI (1) SI0999843T1 (sh)
SK (1) SK284873B6 (sh)
TR (1) TR200000261T2 (sh)
UA (1) UA61968C2 (sh)
WO (1) WO1999006051A1 (sh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
ES2192136B1 (es) * 2002-01-04 2005-03-16 Italfarmaco, S.A. Composiciones farmaceuticas para el tratamiento o prevencion de la osteoporosis.
ITFI20030194A1 (it) * 2003-07-17 2005-01-18 Menarini Int Operations Lu Sa Composizione farmaceutiche effervescenti contenenti
KR100898970B1 (ko) 2004-05-24 2009-05-25 니코메드 파마 에이에스 칼슘-함유 화합물 및 당알코올을 포함하는 입상체
CN1997362B (zh) 2004-06-01 2010-09-08 奈科明制药有限公司 包括含钙化合物作为活性物质的可咀嚼、可吮吸和可吞咽片剂
EP1845949B1 (en) 2005-02-03 2008-05-21 Nycomed Pharma AS Melt granulation of a composition containing a calcium-containing compound
CN103479582A (zh) 2005-02-03 2014-01-01 武田奈科明有限公司 制备含钙组合物的快速湿聚结方法
JP5303276B2 (ja) * 2005-10-12 2013-10-02 プロヴェンティヴ セラピュティックス リミテッド ライアビリティ カンパニー ２５−ヒドロキシビタミンｄ不足および欠乏を治療するための方法および製品
CN101365426B (zh) 2005-12-07 2012-08-08 奈科明制药有限公司 预先压实的含钙组合物
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
CA2835910C (en) * 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
MX2011004744A (es) 2008-11-17 2011-05-30 Nycomed Pharma As Estabilidad mejorada de disolucion de tabletas de carbonato de calcio.
TR200900880A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik bileşimler.
TR200900878A2 (tr) 2009-02-05 2010-08-23 Bi̇lgi̇ç Mahmut Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20120015913A1 (en) 2010-07-15 2012-01-19 Delansorne Remi Formulations of 14-EPI-Analogues of Vitamin D
JP6554034B2 (ja) * 2013-08-09 2019-07-31 日東薬品工業株式会社 カルシウム剤
CN105166935B (zh) * 2015-09-01 2018-08-31 张伟 一种含有维生素d3的液体制剂及其制备方法
SG11202010792TA (en) 2018-05-02 2020-11-27 Ferring Bv Improved pharmaceutical formulations
KR102211287B1 (ko) * 2018-12-21 2021-02-03 (주)휴온스 비타민 d 또는 이의 유도체를 포함하는 안정성이 개선된 액상 제제
MX2023010739A (es) * 2021-03-12 2023-09-20 Nicoventures Trading Ltd Productos orales con sistema autoemulsificante.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073271A1 (en) * 1969-12-11 1971-10-01 Boivin Jean Calcium salt - vitamin d2 compn - for treatment of decalcification of
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
DK8603837A (sh) * 1985-08-13 1987-02-14
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
EP0730862A1 (en) * 1990-05-16 1996-09-11 Zbigniew Walaszek Formulation containing glucaric acid for the prevention or treatment of non-cancerous cellular hyperproliferation and dietary supplement
RO113611B1 (ro) * 1990-08-03 1998-09-30 Asta Pharma Ag Preparate solide de ifosfamida, administrate oral si procedeu de obtinere
IL103224A (en) * 1992-09-18 1998-08-16 Teva Pharma Stabilized pharmaceutical compositions containing derivatives of vitamins d2 and d3
FR2724844B1 (fr) * 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
FR2760639B1 (fr) * 1997-03-14 2000-09-22 Innothera Lab Sa Association therapeutique mineralo-vitaminique sous forme de preparation unitaire liquide buvable

Also Published As

Publication number Publication date
CA2299420C (en) 2009-04-21
IL134268A0 (en) 2001-04-30
ID23504A (id) 2000-04-27
NO20000310D0 (no) 2000-01-21
PL189295B1 (pl) 2005-07-29
RS49703B (sr) 2007-12-31
CZ2000199A3 (cs) 2000-05-17
DE69825164D1 (de) 2004-08-26
BR9810832A (pt) 2000-07-25
SK284873B6 (sk) 2006-01-05
US7067154B1 (en) 2006-06-27
NO20000310L (no) 2000-01-21
EP0999843A1 (en) 2000-05-17
SK802000A3 (en) 2000-07-11
KR20010022319A (ko) 2001-03-15
ITFI970184A1 (it) 1999-01-30
CZ297670B6 (cs) 2007-02-28
ATE271387T1 (de) 2004-08-15
HUP0100539A2 (hu) 2001-08-28
SI0999843T1 (en) 2005-02-28
WO1999006051A1 (en) 1999-02-11
EP0999843B1 (en) 2004-07-21
BG65044B1 (bg) 2007-01-31
EE04046B1 (et) 2003-06-16
ES2223135T3 (es) 2005-02-16
HU226112B1 (en) 2008-04-28
HK1027751A1 (en) 2001-01-23
JP2001511453A (ja) 2001-08-14
TR200000261T2 (tr) 2000-09-21
EA002492B1 (ru) 2002-06-27
EA200000181A1 (ru) 2000-10-30
BR9810832B1 (pt) 2010-11-16
CA2299420A1 (en) 1999-02-11
UA61968C2 (en) 2003-12-15
BG104057A (en) 2000-07-31
AU8978198A (en) 1999-02-22
PT999843E (pt) 2004-11-30
IS5359A (is) 2000-01-24
EE200000054A (et) 2000-10-16
KR100573421B1 (ko) 2006-04-26
JP4497496B2 (ja) 2010-07-07
PL338237A1 (en) 2000-10-09

Similar Documents

Publication Publication Date Title
YU3700A (sh) Farmaceutske kompozicije koje sadrže vitamin d i kalcijum, njihovo dobijanje i upotreba
HUP9802448A3 (en) Inhibitors of platelet aggregation, preparation and use thereof and pharmaceutical compositions
GR3031526T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HUP9901199A3 (en) Tropane-derivatives, inhibiting neurotransmitter re-uptake, their preparation, pharmaceutical compositions containing them and use of the compounds
IL113812A0 (en) Copolymer-1, pharmaceutical compositions containing it and its use
HK1017895A1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
HUP9801880A3 (en) Novel cryptophycins, their use and pharmaceutical compositions containing them
IL117878A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
GR3036410T3 (en) Taxoids, their preparation and pharmaceutical compositions containing them
HU9601219D0 (en) Novel taxoids, their preparation and pharmaceutical compositions containing them
IL121969A0 (en) 10,13,15-trioxatricyclo[9.2.1.1.9.6]-pentadecanone derivatives their preparation and pharmaceutical compositions containing them
IL108624A0 (en) Pseudopeptides, their preparation and pharmaceutical compositions containing them
HUP9802042A3 (en) Taxoids, preparation thereof, and pharmaceutical compositions containing same
AU4834596A (en) Cosmetic or pharmaceutical compositions containing an ozonide-enriched natural vegetable oil, and uses thereof
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
IL124415A (en) N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
ZA9711734B (en) Novel farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments.
GR3036411T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
ZA9811787B (en) Novel farnesyl transferase inhibitors, their preparation, pharmaceutical compositions which contain them and their use for the preparation of medicaments.
MX9605074A (es) Formulacion solida microbicida.
SI0885208T1 (en) Taxoids, their preparation and pharmaceutical compositions containing them
SI0817779T1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
SI0817780T1 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
SI0821680T1 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same